OCUL · Ocular Therapeutix Inc
United States · RS rating 26 · As of 2026-11-03
| Price | 6.82 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 43 / 31 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 8 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +23.7% |
| Sales growth Q/Q | -8.9% |
| Distance from 52-week high | +57.7% |
| Market cap (USD) | $2.1B |